Loading...

Mainz Biomed B.V.

MYNZ•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.70
$-0.04(-5.07%)
U.S. Market opens in 23h 4m

Mainz Biomed B.V. (MYNZ) Stock Overview

Explore Mainz Biomed B.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9M
P/E Ratio-0.26
EPS (TTM)$-5.28
ROE-10.25%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.18
3 Months$0.00
1 Year Target$0.00

MYNZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mainz Biomed B.V. (MYNZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.26 and a market capitalization of 2.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
45.83%
1-Month Change
-5.07%
3-Month Change
-41.18%
6-Month Change
-52.70%
Year-to-Date (YTD) Change
-37.50%
1-Year Change
-79.04%
3-Year Change
-99.70%
5-Year Change
-99.82%
All-Time (Max) Change
-99.82%

Contact Information

https://mainzbiomed.com
49 6131 554 2860
Robert Koch Strasse 50, Mainz, NaN, 55129

Company Facts

190 Employees
IPO DateNov 5, 2021
CountryDE

Frequently Asked Questions